*Actual product packaging may differ from the image shown.
Tesamorelin
Tesamorelin is a growth hormone–releasing hormone (GHRH) analog that stimulates the body’s natural production of growth hormone, with a particular focus on fat metabolism and body composition. Unlike direct growth hormone therapy, Tesamorelin signals the pituitary gland to release growth hormone in a controlled, physiologic way, leading to downstream effects on fat reduction, especially visceral (deep abdominal) fat, while supporting lean muscle, recovery, and metabolic health. Tesamorelin may be a good option for individuals looking to improve body composition, metabolic efficiency, and recovery through targeted growth hormone pathway support.
Protocols developed under the clinical direction of Dr. Jonathann Kuo, MD
Select Size:
What happens after checkout
- ①Purchase your treatment
- ②Complete your Qualiphy consultation via email (~3 min)
- ③Licensed provider reviews & approves your prescription
- ④Pharmacy ships within 3–5 days of approval
After checkout, you'll receive an email to complete your telehealth consultation. A licensed provider must approve before your order ships.
Potential benefits may include:
- Stimulates natural growth hormone release
- Helps reduce visceral and stubborn abdominal fat
- Supports lean muscle mass and body composition
- Improves metabolic health and insulin sensitivity
- Enhances recovery from exercise or physical stress
- May support energy levels and overall vitality
- Pregnancy or Breastfeeding: Safety has not been established; use is not recommended.
- Active Cancer or Recent Cancer Treatment: Growth hormone–pathway therapies are generally avoided.
- Known Allergy: Avoid use if you have a sensitivity to Tesamorelin or formulation components.
- Severe Liver or Kidney Disease: Should be used only under medical supervision.
Mild, short-term side effects may occasionally occur, particularly with initial use or higher doses, including:
- Temporary redness, tenderness, or itching at the injection site
- Mild headache or light fatigue as growth hormone signaling adjusts
- Temporary flushing or warmth
- Mild nausea or stomach discomfort
- Increased appetite, especially early in therapy
- Changes in sleep patterns or vivid dreams (often related to growth hormone activity)
These effects are typically mild and resolve as the body adapts. Starting with a lower dose and gradually increasing can help assess tolerance and minimize side effects.
Regular provider check-ins and periodic bloodwork are recommended to monitor response to therapy, including tracking IGF-1 levels, to ensure growth hormone stimulation remains within healthy, physiologic ranges.
For safe and informed use, review the Extension Health Injection Reaction Guide (PDF), which outlines what to expect, how to reduce discomfort, and when to seek medical support.
- Weeks 1-2: Tesamorelin begins stimulating the pituitary gland to release growth hormone in a controlled, physiologic manner. Early effects are primarily hormonal and metabolic rather than visible. Some patients notice improvements in sleep quality, overnight recovery, or morning energy during this phase.
- Weeks 3–6: As growth hormone signaling becomes more consistent, Tesamorelin’s effects on fat metabolism become more apparent. Patients may begin to notice gradual changes in body composition, improved exercise recovery, and increased energy, especially when paired with nutrition and regular movement.
- Weeks 8–12: With continued use, more noticeable improvements in fat distribution, lean muscle preservation, metabolic health, and overall vitality may occur. Recovery capacity and physical resilience often improve during this phase. Results tend to be steady and cumulative, making Tesamorelin well suited for body recomposition, metabolic optimization, and long-term health.